Verition Fund Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,513
Closed -$94.3K 3765
2025
Q3
$94.3K Buy
+13,513
New +$93.9K ﹤0.01% 3605
2025
Q2
Sell
-57,195
Closed -$435K 3768
2025
Q1
$435K Buy
57,195
+34,299
+150% +$287K ﹤0.01% 2666
2024
Q4
$220K Buy
22,896
+751
+3% +$5.85K ﹤0.01% 2936
2024
Q3
$131K Buy
+22,145
New +$147K ﹤0.01% 2966
2023
Q4
Sell
-26,194
Closed -$191K 2552
2023
Q3
$191K Sell
26,194
-59,012
-69% -$440K ﹤0.01% 1984
2023
Q2
$563K Buy
85,206
+73,206
+610% +$373K 0.01% 1171
2023
Q1
$40.9K Buy
+12,000
New +$46.5K ﹤0.01% 1974
2021
Q3
Sell
-34,920
Closed -$437K 2158
2021
Q2
$437K Buy
+34,920
New +$378K ﹤0.01% 1148
2017
Q4
Sell
-39,549
Closed -$470K 1093
2017
Q3
$470K Buy
39,549
+4,979
+14% +$73.8K 0.04% 611
2017
Q2
$518K Buy
+34,570
New +$461K 0.05% 402
2016
Q4
Sell
-13,500
Closed -$116K 1309
2016
Q3
$116K Buy
+13,500
New +$107K 0.01% 1066

Other funds holding MDXG

Verition Fund Management's MDXG Position: Q4 2025 in Review

Verition Fund Management sold out of MiMedx Group (MDXG) in Q4 2025, closing a stake of 13,513 shares — an estimated $94.3K sold.

Verition Fund Management first reported a position in MDXG in Q3 2016 and held it in 11 quarters. The position peaked at $563K in Q2 2023. 233 funds tracked by Wall St. Rank hold MDXG as of Q4 2025.

  • Verition Fund Management reported no remaining MiMedx Group position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 13,513 MiMedx Group shares in Q4 2025, an estimated $94.3K.
  • Verition Fund Management first reported a position in MiMedx Group in Q3 2016 and held it in 11 quarters.
  • Verition Fund Management's MiMedx Group position peaked at $563K in Q2 2023.
  • 233 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.